Search hospitals > Georgia > Atlanta
Atlanta Diabetes Associates
Claim this profileAtlanta, Georgia 30318
Global Leader in Type 1 Diabetes
Global Leader in Diabetes
Conducts research for Type 2 Diabetes
Conducts research for Diabetes Mellitus
Conducts research for Hypoglycemia
113 reported clinical trials
2 medical researchers
Summary
Atlanta Diabetes Associates is a medical facility located in Atlanta, Georgia. This center is recognized for care of Type 1 Diabetes, Diabetes, Type 2 Diabetes, Diabetes Mellitus, Hypoglycemia and other specialties. Atlanta Diabetes Associates is involved with conducting 113 clinical trials across 68 conditions. There are 2 research doctors associated with this hospital, such as Bruce Bode, MD and Quentin Van Meter, M.D..Area of expertise
1Type 1 Diabetes
Global LeaderStage III
GAD-65 positive
IA-2 positive
2Diabetes
Global LeaderStage III
GAD-65 positive
IA-2 positive
Top PIs
Bruce Bode, MDAtlanta Diabetes Associates4 years of reported clinical research
Expert in Type 1 Diabetes
Studies Type 2 Diabetes
16 reported clinical trials
25 drugs studied
Quentin Van Meter, M.D.Van Meter Pediatric Endocrinology, P.C.4 years of reported clinical research
Studies Human Growth Hormone Deficiency
Studies Somatropin in Idiopathic Short Stature Patients
1 reported clinical trial
1 drug studied
Clinical Trials running at Atlanta Diabetes Associates
Type 1 Diabetes
Cardiovascular Disease
Obesity
Atherosclerosis
Hypothyroidism
Prader-Willi Syndrome
Elevated Lipoprotein
Thyroid Disease
Generalized Lipodystrophy
Lipoatrophy
Weekly vs Daily Insulin
for Type 1 Diabetes
This study compares insulin icodec, an insulin taken once a week to insulin glargine, an insulin taken once a day. The study medicine will be investigated in participants with type 1 diabetes. The study will look at how well insulin icodec taken weekly controls blood sugar compared to insulin glargine taken daily. The study will last for about 8.5 months.
Recruiting2 awards Phase 3
Cadisegliatin
for Type 1 Diabetes
This is a Phase 3 trial of cadisegliatin as adjunctive therapy to insulin in participants with Type 1 Diabetes Mellitus.
Recruiting1 award Phase 33 criteria
Tirzepatide
for Type 1 Diabetes and Obesity
The main purpose of this study is to find out how well and how safely tirzepatide works in adults who have type 1 diabetes and obesity or overweight. Participation in the study will last about 49 weeks.
Recruiting1 award Phase 31 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Atlanta Diabetes Associates?
Atlanta Diabetes Associates is a medical facility located in Atlanta, Georgia. This center is recognized for care of Type 1 Diabetes, Diabetes, Type 2 Diabetes, Diabetes Mellitus, Hypoglycemia and other specialties. Atlanta Diabetes Associates is involved with conducting 113 clinical trials across 68 conditions. There are 2 research doctors associated with this hospital, such as Bruce Bode, MD and Quentin Van Meter, M.D..
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.